Breaking News

NEW YORK, Oct. 24 – A limping economy set back Applied Biosystems’ profit by 34 percent in the first quarter while reduced research spending shrank Celera Genomics’ losses in the period, the companies said separately on Wednesday.

This article has been updated from a previous version   NEW YORK, October 24 –Despite soaring sales of GeneChip microarrays, Affymetrix reported flat third-quarter revenues Wed

NEW YORK, Oct. 24 - Abbott Laboratories has agreed to acquire Vysis in a stock deal worth about $355 million in an attempt to buttress its position in the DNA-based diagnostic market, the drug giant announced on Wednesday.

SAN FRANCISCO, Oct. 24 – Genaissance Pharmaceuticals on Wednesday posted third-quarter revenues of $1.1 million compared to $67,000 for the same quarter a year ago, the company announced.

SAN FRANCISCO, Oct. 24 – Pyrosequencing on Wednesday posted third-quarter revenues of $2.5 million compared to $1 million for the same quarter a year ago, the company announced.

NEW YORK, Oct. 24 - Genomic Solutions has sold one of its Investigator ProGest protein digestion station to the University of Calgary, the company said on Wednesday.

NEW YORK, Oct. 23 - Incyte Genomics and Genentech have struck a licensing deal that covers patents covering therapeutic antibodies to four proteins discovered by Incyte, the companies said on Tuesday.

NEW YORK, Oct. 23 - Amersham Biosciences said on Tuesday that the US Department of Energy's Joint Genome Institute has bought 21 of its MegaBACE 4000 DNA analysis system.

NEW YORK, Oct. 23 - Proteomics and pharmacogenomics firm Aspira Biosystems has won a Small Business Innovation Research grant from the National Institutes of Health, the company said on Tuesday.

NEW YORK, Oct. 23 - Celera Genomics has turned its gaze heavenward in its quest for more powerful bioinformatics.

SAN FRANCISCO, Oct. 23 – Cepheid on Tuesday posted third-quarter revenues of $2.8 million versus $2.3 for the same quarter a year ago, the company announced.

NEW YORK, Oct. 22 - DoubleTwist has licensed its Prophecy database, its Prophecy ToolKit, and its Genomatrix Promoter Resource database to pharmaceutical firm Organon, the bioinformatics company said on Monday. Financial terms of the agreement were not disclosed.

NEW YORK, Oct. 22 - Third Wave Technologies has appointed Otsuka Pharmaceutical to be its exclusive distributor of Invader research products in China, Egypt, Indonesia, Japan, Pakistan, the Philippines, South Korea, and Thailand, Third Wave said on Monday.

NEW YORK, Oct. 22 – NetGenics has licensed its DiscoveryCenter integration software product to Avalon Pharmaceuticals to help it integrate its genomic, cytogenetic, and chemistry data, Avalon said on Monday.

As the methodology of genomics finds broader applications, it influences discoveries in many different fields.

NEW YORK, Oct.

An -ome is Born

SAN FRANCISCO, Oct. 19 – In the beginning, there was the genome. Then came the proteome.

NEW YORK, Oct. 19 - Invitrogen has been granted a non-exclusive sub-license from Gryphon Sciences to use its Native Chemical Ligation patent, which allow researchers to synthesize proteins using chemical, rather than biological means, Gryphon said on Friday.

NEW YORK, Oct. 18 - Fiber-optic giant Corning has pulled the plug on its microarray venture, Corning Microarray Technologies, as part of an overall restructuring effort to trim costs, the company said on Thursday.

Pages

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.